AF (Atrial Fibrillation) – Overall learning assessment

These promotional educational meetings have been developed by Soar Beyond and the Bristol Myers Squibb (BMS)/Pfizer Alliance and are fully funded by the BMS/Pfizer Alliance. These online resources have been co-developed by Soar Beyond, the BMS/Pfizer Alliance, and a Clinical Pharmacist and General Practitioner faculty chosen by the BMS/Pfizer Alliance.

This is to be used as a guide only and should be used to augment local guidelines or pathways. Pharmacists are encouraged to link with a GP prescribing/atrial fibrillation lead for supervision and mentorship to support clinical competence.


This digital material is for use by healthcare professionals and is intended to be reviewed online only. Do not distribute. For Prescribing information, click here.

All information provided in this module is for reference only, the latest version of the Summary of Product Characteristics should be consulted when making prescribing decisions.

Adverse events should be reported. Reporting forms and information can be found here, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via [email protected] or 08007311736 (UK).


Job Bag Number: 432UK2001128-03

Date of preparation: November 2020

AF : Atrial Fibrillation

NVAF : Non-Valvular Atrial Fibrilation